NCT06710379View on ClinicalTrials.gov

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions
Solid Tumors
Interventions
DRUG

ADRX-0405

Antibody Drug Conjugate targeting STEAP1

Trial Locations (8)

22031

RECRUITING

NEXT Virginia, Fairfax

49546

RECRUITING

START Midwest, Grand Rapids

55455

RECRUITING

University of Minnesota Masonic Cancer Center, Minneapolis

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

78758

RECRUITING

NEXT Austin, Austin

84119

RECRUITING

START Mountain Region, West Valley City

90404

RECRUITING

UCLA, Santa Monica

91010

RECRUITING

City of Hope, Duarte

Sponsors
All Listed Sponsors
lead

Adcentrx Therapeutics

INDUSTRY